Throat Sprays Market Share

The North America throat sprays market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036, backed by the presence of various major throat sprays manufacturers, a huge number of public awareness campaigns aimed at reducing infectious diseases, and the growing population of elderly people in the region. For instance, the number of adults aged 65 and over had increased by nearly 53 million in 2021, and it is expected to reach 86 million by 2050.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of throat sprays is assessed at USD 508.84 Million.

The throat sprays market size was over USD 492.01 Million in 2023 and is likely to reach USD 798.99 Million by the end of 2036, growing at around 3.8% CAGR during the forecast period i.e., between 2024-2036. Rising level of air pollution, rise in prevalence of strep throat problem, upsurge in rhinitis, and spike in upper respiratory infections are some major factors driving the growth of the market.

North America is expected to account for largest industry share by 2036, backed by presence of various major throat sprays manufacturers, a huge number of public awareness campaigns aimed at reducing infectious diseases, and growing population of elderly people in the region.

Reckitt Benckiser Group PLC, Procter & Gamble Company, Prestige Consumer Healthcare Inc., Purdue Pharma L.P., Marinomed Biotech AG, Biocidin Botanicals, Melcare Biomedical Pty Ltd, Ursatec GmbH, Puressentiel UK Ltd

Throat Sprays Market Share